君圣泰医药(02511.HK)折让12%配股 净筹逾2亿元

阿斯达克财经
Aug 03

君圣泰医药(02511.HK) 宣布,计划配售最多9,900万股新股,配售股份占扩大后已发行股本约14.77%,配售价以每股2.28元,较7月31日收市价2.6元折让约12.31%。假设悉数配售,所得款项总额约2.26亿元,所得净额约2.23亿元。所得款项净额中,约30%用于HTD1801针对二型糖尿病的商业化工作;约45%用于拓展HTD1801研发至全新适应症;约15%用于其他候选药物研发;约...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10